Ignite Creation Date:
2024-05-06 @ 9:58 AM
Last Modification Date:
2024-10-26 @ 12:22 PM
Study NCT ID:
NCT03123783
Status:
COMPLETED
Last Update Posted:
2023-12-26
First Post:
2017-04-17
Brief Title:
CD40 Agonistic Antibody APX005M Sotigalimab in Combination With Nivolumab
Sponsor:
Apexigen America Inc
Organization:
Apexigen America Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-07-10
Start Date Type:
ACTUAL
Primary Completion Date:
2020-11-16
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-11-16
Completion Date Type:
ACTUAL
First Submit Date:
2017-04-17
First Submit QC Date:
April 18 2017
Study First Post Date:
2017-04-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2023-12-05
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
2021-11-01
Disp First Submit QC Date:
November 13 2023
Disp First Post Date:
2023-12-05
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2023-12-21
Last Update Post Date:
2023-12-26
Last Update Post Date Type:
ACTUAL